Delivery Order SPE2DB20D3111-SPE2DB25FA9UN
- Not listed
- The Defense Logistics Agency awarded a $26,579.88 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded, firm fixed-price contract represents a small component of the vendor's extensive pharmaceutical supply operations supporting federal medical procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,476.68 to AmerisourceBergen Drug Corp for the supply of Rotarix Vaccine Oral Syringe 1.5ML, with an ultimate completion date of August 14, 2025. The award was made on August 13, 2025, using firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $24,953.40 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe 1.5ml format. This firm fixed-price contract, with an ultimate completion date of September 2, 2025, was competitively awarded without set-aside designation. The performance location is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single procurement action under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $6,959.21 to AmerisourceBergen Drug Corp for Rotarix vaccine in oral syringe format (1.5ml) on September 16, 2025, with completion scheduled for September 17, 2025. This competitively awarded, firm fixed-price delivery order was placed under no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,953.32 to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5mL) with a firm fixed price contract type. This non-set-aside award was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rotarix Vaccine oral syringes (1.5mL) under a firm fixed-price contract valued at $8,212.02, with a completion date of September 2, 2025. This non-set-aside, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The delivery order will be...
- The Defense Logistics Agency awarded a delivery order valued at $2,214.99 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe format (1.5ML) on September 9, 2025, with completion expected by September 10, 2025. This firm fixed-price delivery order represents a non-competed procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $6,644.97 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe format (1.5 milliliter units). This firm fixed-price delivery order, executed on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5mL) under a firm fixed-price contract valued at $11,462.30. The order, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-competitive, non-set-aside delivery of pharmaceutical products to support federal medical supply requirements. Performance will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Rotarix vaccine in oral syringe format (1.5mL) with a ceiling value of $8,304.72. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is set to be completed by August 13, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA9UNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,953.32 to AmerisourceBergen Drug Corp for Rotarix vaccine in oral syringe format (1.5mL) on September 25, 2025, with completion targeted for September 26, 2025. This competitive, firm fixed-price delivery order was issued without a set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, maintains extensive experience fulfilling Defense Logistics Agency medical supply requirements through a diversified portfolio of brand-name and generic medications, vaccines, and specialized medical commodities. The company's federal contract performance demonstrates consistent capability to meet open competition requirements across delivery orders ranging substantially in value. This vaccine delivery order supports the Defense Health Agency and broader military healthcare infrastructure by providing immunization products essential to medical readiness and troop health maintenance.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 9/25/25 |